AnGes, Inc. (4563.T)

JPY 78.0

(5.41%)

Total Liabilities Summary of AnGes, Inc.

  • AnGes, Inc.'s latest annual total liabilities in 2023 was 2.78 Billion JPY , down -66.77% from previous year.
  • AnGes, Inc.'s latest quarterly total liabilities in 2024 Q2 was 2.19 Billion JPY , down -26.15% from previous quarter.
  • AnGes, Inc. reported annual total liabilities of 8.39 Billion JPY in 2022, up 23.08% from previous year.
  • AnGes, Inc. reported annual total liabilities of 6.82 Billion JPY in 2021, up 20.2% from previous year.
  • AnGes, Inc. reported quarterly total liabilities of 2.97 Billion JPY for 2024 Q1, up 6.72% from previous quarter.
  • AnGes, Inc. reported quarterly total liabilities of 8.49 Billion JPY for 2023 Q1, up 1.22% from previous quarter.

Annual Total Liabilities Chart of AnGes, Inc. (2023 - 2008)

Historical Annual Total Liabilities of AnGes, Inc. (2023 - 2008)

Year Total Liabilities Total Liabilities Growth
2023 2.78 Billion JPY -66.77%
2022 8.39 Billion JPY 23.08%
2021 6.82 Billion JPY 20.2%
2020 5.67 Billion JPY 1109.36%
2019 469.25 Million JPY 48.4%
2018 316.21 Million JPY -7.47%
2017 341.72 Million JPY -48.98%
2016 669.81 Million JPY 26.23%
2015 530.63 Million JPY 18.16%
2014 449.08 Million JPY 24.53%
2013 360.63 Million JPY -30.87%
2012 521.67 Million JPY -15.62%
2011 618.21 Million JPY -13.72%
2010 716.49 Million JPY 10.36%
2009 649.21 Million JPY -9.15%
2008 714.62 Million JPY 0.0%

Peer Total Liabilities Comparison of AnGes, Inc.

Name Total Liabilities Total Liabilities Difference
KOHJIN BIO CO LTD 3.24 Billion JPY 14.092%
PRISM BioLab Co.,LTD 63.41 Million JPY -4298.872%
GNI Group Ltd. 26.34 Billion JPY 89.411%
Linical Co., Ltd. 10.3 Billion JPY 72.932%
Trans Genic Inc. 3.81 Billion JPY 26.837%
MEDINET Co., Ltd. 590.2 Million JPY -372.611%
Soiken Holdings Inc. 697.02 Million JPY -300.183%
Cytori Cell Research Institute, Inc. 3.02 Billion JPY 7.66%
OncoTherapy Science, Inc. 513.6 Million JPY -443.094%
Nxera Pharma Co., Ltd. 90.38 Billion JPY 96.914%
Immuno-Biological Laboratories Co., Ltd. 353.27 Million JPY -689.583%
NanoCarrier Co., Ltd. 1.64 Billion JPY -69.064%
Carna Biosciences, Inc. 472.35 Million JPY -490.524%
CanBas Co., Ltd. 91.98 Million JPY -2932.318%
D. Western Therapeutics Institute, Inc. 1.09 Billion JPY -155.062%
RaQualia Pharma Inc. 809.83 Million JPY -244.439%
Chiome Bioscience Inc. 593.73 Million JPY -369.803%
Kidswell Bio Corporation 4.25 Billion JPY 34.431%
PeptiDream Inc. 29.11 Billion JPY 90.419%
Oncolys BioPharma Inc. 566.5 Million JPY -392.386%
Ribomic Inc. 155.8 Million JPY -1690.249%
SanBio Company Limited 2.25 Billion JPY -23.703%
Healios K.K. 11.28 Billion JPY 75.285%
BrightPath Biotherapeutics Co., Ltd. 251.26 Million JPY -1010.113%
Kubota Pharmaceutical Holdings Co., Ltd. 369 Million JPY -655.927%
Delta-Fly Pharma, Inc. 241.49 Million JPY -1055.033%
StemRIM 187 Million JPY -1391.641%
CellSource Co., Ltd. 677.73 Million JPY -311.57%
FunPep Company Limited 189.32 Million JPY -1373.331%
Kringle Pharma, Inc. 596.95 Million JPY -367.266%
Stella Pharma Corporation 1.44 Billion JPY -93.222%
TMS Co., Ltd. 97.68 Million JPY -2755.356%
Noile-Immune Biotech Inc. 91.49 Million JPY -2948.691%
Cuorips Inc. 200.96 Million JPY -1288.015%
K Pharma,Inc. 209.13 Million JPY -1233.771%
Takara Bio Inc. 11.42 Billion JPY 75.575%
ReproCELL Incorporated 741.03 Million JPY -276.417%
PhoenixBio Co., Ltd. 917.71 Million JPY -203.948%
StemCell Institute Inc. 3.85 Billion JPY 27.558%
Japan Tissue Engineering Co., Ltd. 908.43 Million JPY -207.053%
CellSeed Inc. 301.04 Million JPY -826.556%